Associate announcement

Kaitlin Soye Joins Lenczner Slaght

Lenczner Slaght adds another exceptional litigator to its expert Intellectual Property team.

January 22, 2019

Canada’s leading litigation firm is pleased to welcome Kaitlin Soye. Kaitlin comes to us from a leading international law firm with proven experience in advocacy. Adding to our team’s varied technical backgrounds, diverse thinking, and deep understanding of the IP landscape, Kaitlin will further enhance our ability to protect clients’ valuable IP.

Kaitlin’s practice encompasses a broad range of intellectual property litigation, including pharmaceutical and biologics patents, food and drug regulatory, oil and gas, and telecommunications. During law school, Kaitlin worked as a research associate in the Centre of Genomics and Policy. She also volunteered at the McGill Legal Information Clinic and the Concordia Legal Information Clinic. Prior to law school, she completed her B.Sc. in Molecular Biology from the University of Guelph, her M.Sc. in Microbiology and Immunology and her Ph.D. in Experimental Medicine from McGill University. She has extensive research experience in molecular biology, biochemistry, and infectious disease.

Welcome, Kaitlin!

Lenczner Slaght

Lenczner Slaght

Widely recognized as Canada's leading litigation practice, Lenczner Slaght has successfully represented clients' interests in some of the country's most complex and high-profile cases. Our lawyers are distinguished by their depth of courtroom experience, appearing at all levels of the courts, before tribunals, and in mediation and arbitration proceedings. We're also known for our wealth of talent: Lenczner Slaght partners, ranked among the best of their peers nationally, recruit and mentor gifted litigators who uphold the highest professional standards. From commercial disputes and class actions to professional regulation and cross-border matters, we bring expert strategy to all areas of litigation.

View All Announcements by This Firm

Recent lawyer announcements

test

January 21, 2026